Logotype for Storebrand

Storebrand (STB) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Storebrand

Q2 2024 earnings summary

3 Feb, 2026

Executive summary

  • Cash-based earnings reached NOK 2,249 million in Q2 2024, up from NOK 856 million in Q2 2023, driven by operational growth, cost control, and a NOK 1,047 million gain from the divestment of Storebrand Health Insurance.

  • Solvency II ratio remained robust at 191%, well above the overcapitalisation threshold.

  • Double-digit growth across all business lines: 14% in AUM, 19% in Unit Linked reserves, and 16% in insurance premiums year-over-year.

  • Ongoing share buyback program, with NOK 1.1 billion tranche initiated in Q2 and NOK 409 million completed; total 2024 buybacks to reach NOK 1.5 billion.

  • Strategic acquisitions included increasing AIP Management stake to 60% and purchasing the Lysaker Park headquarters.

Financial highlights

  • Group cash equivalent earnings before amortisation: NOK 2,249 million in Q2 2024, up from NOK 856 million in Q2 2023.

  • Fee and administration income up 13% year-over-year to NOK 1,888 million.

  • Cash earnings per share after tax at a record NOK 4.59.

  • Combined insurance premiums up 16% year-over-year, mainly due to price increases.

  • Group profit before amortisation and tax (IFRS) was NOK 2,546 million in Q2 2024, up from NOK 616 million in Q2 2023.

Outlook and guidance

  • On track to achieve NOK 5 billion profit ambition and 14% return on equity target for 2025.

  • Cost guidance for 2024 maintained at NOK 5.9 billion, excluding integration, currency, and performance-related costs.

  • Combined insurance ratio targeted to return to 90-92% by 2025, with current ratio at 97%.

  • Share buybacks of NOK 1.5 billion per year, aiming for NOK 12 billion by 2030.

  • Gradual opening of the public sector pension market expected, with more municipalities entering tenders.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more